Astellas UK is suspended from membership of the Association of the British Pharmaceutical Industry (ABPI)
Press Release 24 June 2016
Astellas UK has been suspended from membership of the Association of the British Pharmaceutical Industry (ABPI) with effect from June 24th 2016.
This is in connection with a serious matter which came to light during the PMCPA’s consideration of two complaints and, as a consequence, Astellas UK and Astellas Europe were reported to the ABPI Board. Full details can be found in the case reports AUTH2780/7/15 and AUTH/2747/1/15.
The ABPI has issued a press release which can be found here.